HHS vs HNI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 13, 2026

HHS

39.9
AI Score
VS
HHS Wins

HNI

36.9
AI Score

Investment Advisor Scores

HHS

40score
Recommendation
SELL

HNI

37score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric HHS HNI Winner
Forward P/E 14.2857 12.3153 HNI
PEG Ratio 1.1907 0.6155 HNI
Revenue Growth -10.3% 120.7% HNI
Earnings Growth -90.3% -31.5% HNI
Tradestie Score 39.9/100 36.9/100 HHS
Profit Margin -0.7% 0.1% HNI
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

HHS 1M: +13.1% · 3M: +1.4% HNI 1M: +22.0% · 3M: +58.9%

Current Technical Phase

HHS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 67

RSI (14): 67.4 · Price: $2.81

HNI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (15.8% over 20 days), RSI 74

RSI (14): 74.3 · Price: $49.36

Fundamentals Snapshot

Metric HHS HNI
Market Cap
Forward P/E 2.6 10.2
Trailing P/E
Revenue (TTM)
Revenue Growth -0.1% 1.2%
Gross Margin 0.2% 0.4%
Operating Margin 0.0% 0.1%
EPS -0.14 -0.03
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, HHS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.